Renaissance Global Health Care Class FATL1635
No Matches were found for
- NAV45.15
- TODAY'S CHANGE (%)0.66 (1.48%)
- Investment Style
- 52 Week Range
- Distribution Yield0.00%
- MER1.49
- AUM611.9M
- RRSP EligibilityYes
- Load TypeFront-end Load
- Overall Morningstar Rating3 out of 5 Starsout of 274 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select growth of 10k Options
| Date | Percent Change | Category Percent Change |
|---|---|---|
| April 2022 | 3.12% | |
| March 2022 | 3.26% | |
| February 2022 | 3.17% | |
| January 2022 | 3.17% | |
| December 2021 | 3.59% | |
| November 2021 | 3.36% | |
| October 2021 | 3.45% | |
| September 2021 | 3.44% | |
| August 2021 | 3.65% | |
| July 2021 | 3.49% | |
| June 2021 | 3.37% | |
| May 2021 | 3.09% | |
| April 2021 | 3.13% | |
| March 2021 | 3.07% | |
| February 2021 | 3.09% | |
| January 2021 | 3.24% | |
| December 2020 | 3.18% | |
| November 2020 | 3.12% | |
| October 2020 | 2.96% | |
| September 2020 | 3.13% | |
| August 2020 | 3.08% | |
| July 2020 | 3.10% | |
| June 2020 | 3.00% | |
| May 2020 | 3.09% | |
| April 2020 | 2.93% | |
| March 2020 | 2.53% | |
| February 2020 | 2.57% | |
| January 2020 | 2.77% | |
| December 2019 | 2.77% | |
| November 2019 | 2.74% | |
| October 2019 | 2.51% | |
| September 2019 | 2.34% | |
| August 2019 | 2.39% | |
| July 2019 | 2.41% | |
| June 2019 | 2.37% | |
| May 2019 | 2.28% | |
| April 2019 | 2.35% | |
| March 2019 | 2.45% | |
| February 2019 | 2.39% | |
| January 2019 | 2.29% | |
| December 2018 | 2.19% | |
| November 2018 | 2.40% | |
| October 2018 | 2.22% | |
| September 2018 | 2.44% | |
| August 2018 | 2.44% | |
| July 2018 | 2.28% | |
| June 2018 | 2.14% | |
| May 2018 | 2.05% | |
| April 2018 | 1.95% | |
| March 2018 | 2.03% | |
| February 2018 | 2.03% | |
| January 2018 | 2.03% | |
| December 2017 | 1.95% | |
| November 2017 | 2.04% | |
| October 2017 | 1.98% | |
| September 2017 | 1.96% | |
| August 2017 | 1.96% | |
| July 2017 | 1.99% | |
| June 2017 | 2.09% | |
| May 2017 | 2.12% | |
| April 2017 | 2.11% | |
| March 2017 | 2.00% | |
| February 2017 | 2.01% | |
| January 2017 | 1.75% | |
| December 2016 | 1.76% | |
| November 2016 | 1.74% | |
| October 2016 | 1.70% | |
| September 2016 | 1.85% | |
| August 2016 | 1.81% | |
| July 2016 | 1.97% | |
| June 2016 | 1.80% | |
| May 2016 | 1.86% | |
| April 2016 | 1.66% | |
| March 2016 | 1.67% | |
| February 2016 | 1.72% | |
| January 2016 | 1.85% | |
| December 2015 | 2.15% | |
| November 2015 | 2.01% | |
| October 2015 | 1.90% | |
| September 2015 | 1.76% | |
| August 2015 | 1.91% | |
| July 2015 | 2.10% | |
| June 2015 | 1.88% | |
| May 2015 | 1.86% | |
| April 2015 | 1.63% | |
| March 2015 | 1.80% | |
| February 2015 | 1.72% | 0.85% |
| January 2015 | 1.69% | 0.78% |
| December 2014 | 1.38% | 0.67% |
| November 2014 | 1.34% | 0.67% |
| October 2014 | 1.23% | 0.59% |
| September 2014 | 1.11% | 0.56% |
| August 2014 | 1.07% | 0.55% |
| July 2014 | 0.99% | 0.50% |
| June 2014 | 0.96% | 0.49% |
| May 2014 | 0.93% | 0.47% |
| April 2014 | 0.90% | 0.45% |
| March 2014 | 0.94% | 0.47% |
| February 2014 | 1.02% | 0.49% |
| January 2014 | 0.89% | 0.44% |
| December 2013 | 0.75% | 0.42% |
| November 2013 | 0.71% | 0.38% |
| October 2013 | 0.60% | 0.33% |
| September 2013 | 0.53% | 0.28% |
| August 2013 | 0.49% | 0.25% |
| July 2013 | 0.50% | 0.24% |
| June 2013 | 0.42% | 0.21% |
| May 2013 | 0.42% | 0.22% |
| April 2013 | 0.38% | 0.18% |
| March 2013 | 0.35% | 0.17% |
| February 2013 | 0.28% | 0.16% |
| January 2013 | 0.22% | 0.13% |
| December 2012 | 0.13% | 0.09% |
| November 2012 | 0.13% | 0.07% |
| October 2012 | 0.13% | 0.06% |
| September 2012 | 0.14% | 0.08% |
| August 2012 | 0.09% | 0.06% |
| July 2012 | 0.09% | 0.04% |
| June 2012 | 0.10% | 0.05% |
| May 2012 | 0.05% | 0.02% |
| April 2012 | 0.05% | 0.08% |
| March 2012 | 0.07% | 0.11% |
| February 2012 | 0.02% | 0.07% |
| January 2012 | 0.02% | 0.04% |
| December 2011 | 0.00% | 0.00% |
No reports available
Calendar Year Total Returns
| Year | Fund | Best-Fit Index | Category |
|---|---|---|---|
2021 | +9.83% | --- | --- |
2020 | +10.77% | --- | --- |
2019 | +18.16% | --- | --- |
2018 | +8.31% | --- | --- |
2017 | +6.70% | --- | --- |
Asset Class
| US Equity | 73.6% |
|---|---|
| Int'l Equity | 25.3% |
| Cash | 1.1% |
| CDN Equity | 0.0% |
| Other | 0.0% |
| Fixed Income | 0 |
Sectors
| Healthcare | 98.8% |
|---|---|
| Financial Serv.s | 0.1% |
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
Geographic Region
| United States | 74.4% |
|---|---|
| Asia/Oceania | 6.6% |
| Europe | 2.8% |
| Latin America | 0.3% |
| Canada | 0.0% |
| Africa | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
UnitedHealth Group Inc | Long | 8.3% | -0.95% | $66.8M |
Pfizer Inc | Long | 6.6% | -0.95% | $53.2M |
Eli Lilly and Co | Long | 6.1% | +3.39% | $49.0M |
AstraZeneca PLC | Long | 5.0% | -0.95% | $40.1M |
Bristol-Myers Squibb Co | Long | 4.2% | -6.77% | $33.6M |
Novartis AG | Long | 4.0% | -0.95% | $32.3M |
Danaher Corp | Long | 3.6% | -0.94% | $29.0M |
Boston Scientific Corp | Long | 3.1% | -0.95% | $25.3M |
Edwards Lifesciences Corp | Long | 2.9% | -0.95% | $23.4M |
Stryker Corp | Long | 2.3% | -0.95% | $18.9M |
Best Fit Index | MSCI World/Health Care NR CAD |
|---|---|
Category | |
Sponsor | CIBC Asset Management Inc |
Inception | December 12, 2000 |
The fund seeks to obtain long-term capital appreciation by investing primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or whose securities are traded on a U.S. exchange, which are engaged in the design, development, manufacturing, and distribution of products or services in the health care sectors. The Fund will invest in a diversified portfolio, which will mainly include securities in the medical technology, biotechnology, health care, and pharmaceutical sectors.
| Total Net Assets | $140.8M |
|---|---|
| Annual Portfolio Turnover | 38.28% |
| Equity Style | Large Cap Growth |
| Credit Quality / Duration | --- |
| Tax-Adjusted Rating | Not Rated |
| Initial Investment(s) | $500 |
|---|---|
| Subsequent Investment(s) | $100 |
| Initial RRSP Investment(s) | $500 |
| Subsequent RRSP Investment(s) | $100 |
| Maximum Initial Sales Fees | --- |
|---|---|
| Maximum Deferred Sales Fees | --- |
| Actual Management Fee | 1.50% |
| Actual Mgmt. Expense Ratio (MER) | 1.49% |
| Load Type | Front-end Load |
Morningstar Ratings
| Time Horizon | Star Rating | Tax-Adjusted Rating |
|---|---|---|
| Overall | 3 out of 5 Stars | ---No Tax-Adjusted Rating Available |
| 3 Year | 4 out of 5 Stars | ---No Tax-Adjusted Rating Available |
| 5 Year | 3 out of 5 Stars | ---No Tax-Adjusted Rating Available |
| 10 Year | 3 out of 5 Stars | ---No Tax-Adjusted Rating Available |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Management & Contact
Contact Information
CIBC Asset Management Inc161 Bay Street Suite 2230
Toronto ON Canada M5J 2S1
Tel: (416) 364-5620
Fax: (416) 364-4472
Portfolio Manager since January 01, 2013
Ann Gallo